Unfortunately, using third world countries as a barometer in analyzing Heath statistics isn’t very reliable. The same charts in Latin America, where ivermectin is used commonly (and was used for a time to treat COVID), paints a different picture.
In meta-analyses, the studies that came out of Brazil, Chile and others showed no affect of ivermectin on patient outcomes. Although, I didn’t see any on its use as a prophylaxis.